FDA NDC Directory · JSON-LD · Markdown

Neulasta

NDC 55513-099 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namepegfilgrastim
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA125031
Dosage form / routeSOLUTION · SUBCUTANEOUS
Active ingredientsPEGFILGRASTIM (4 mg/.4mL)
Marketing started20260331
Package count1

External sources

Source: openFDA. Public-domain (CC0).